NGL Fine Chem LtdPharmaceuticalsINE887E01022Consolidated₹2777.95+69.40 (+2.56%)Jun-26
Valuation
Market Cap₹1.72K Cr
TTM PE30.00x
Forward PE27.05x
PEG1.57
Book Value₹532.91
P/B5.21x
TTM EPS₹92.59
Fwd EPS₹102.68
TTM Revenue₹536.16 Cr
TTM PAT₹57.21 Cr
TTM EBITDA₹84.18 Cr
TTM EBIT₹63.61 Cr
Last Qtr PAT₹18.40 Cr
Last Qtr EBITDA₹23.29 Cr
Last Qtr EBIT₹18.04 Cr
Profitability
ROE17.38%
ROCE18.32%
TTM NPM10.67%
TTM EBITDA %15.70%
Curr OPM12.55%
Last OPM8.89%
Curr NPM—
Last NPM—
Curr EPS₹29.78
Last EPS₹21.83
Balance sheet
Equity₹3.09 Cr
Reserve₹326.14 Cr
Total Debt₹108.42 Cr
D/E0.33x
Interest %5.38%
Curr Interest₹0.99 Cr
Price / range
Close₹2777.95
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+2.56%
1W+4.31%
1M-8.14%
3M-8.72%
6M+26.47%
1Y+104.04%
2Y+31.33%
3Y+39.44%
5Y-2.69%
Diwali+98.42%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits